|
US5877016A
(en)
*
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
|
CA2411101C
(en)
|
2000-06-05 |
2018-01-16 |
Brigham And Women's Hospital, Inc. |
A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
|
|
IL153375A0
(en)
*
|
2000-06-22 |
2003-07-06 |
Genentech Inc |
Agonist anti-trk-c monoclonal antibodies
|
|
GB0210783D0
(en)
*
|
2002-05-10 |
2002-06-19 |
Polonelli Luciano |
Anti-microbial polypeptides
|
|
CA2505924A1
(en)
*
|
2002-11-13 |
2004-05-27 |
Micromet Ag |
Method for identifying antigen specific b cells
|
|
ATE431157T1
(de)
|
2002-12-23 |
2009-05-15 |
Rinat Neuroscience Corp |
Verfahren zur behandlung von durch taxol induzierter sensorischer neuropathie
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
WO2004084836A2
(en)
*
|
2003-03-20 |
2004-10-07 |
Rinat Neuroscience Corp. |
Methods for treating taxol-induced gut disorder
|
|
JP4503617B2
(ja)
*
|
2003-12-23 |
2010-07-14 |
ライナット ニューロサイエンス コーポレイション |
アゴニスト抗ｔｒｋＣ抗体および該抗体を用いる方法
|
|
AR054260A1
(es)
*
|
2005-04-26 |
2007-06-13 |
Rinat Neuroscience Corp |
Metodos de tratamiento de enfermedades de la neurona motora inferior y composiciones utilizadas en los mismos
|
|
MX2007015292A
(es)
*
|
2005-06-06 |
2008-02-21 |
Wyeth Corp |
Anticuerpos monoclonales anti-trkb y sus usos.
|
|
CN103145837A
(zh)
*
|
2005-06-30 |
2013-06-12 |
Abbvie公司 |
Il-12/p40结合蛋白
|
|
RU2442793C2
(ru)
|
2005-11-30 |
2012-02-20 |
Эбботт Лэборетриз |
АНТИТЕЛА ПРОТИВ ГЛОБУЛОМЕРА Аβ, ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ЧАСТИ, СООТВЕТСТВУЮЩИЕ ГИБРИДОМЫ, НУКЛЕИНОВЫЕ КИСЛОТЫ, ВЕКТОРЫ, КЛЕТКИ-ХОЗЯЕВА, СПОСОБЫ ПОЛУЧЕНИЯ УКАЗАННЫХ АНТИТЕЛ, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ УКАЗАННЫЕ АНТИТЕЛА, ПРИМЕНЕНИЯ УКАЗАННЫХ АНТИТЕЛ И СПОСОБЫ ИСПОЛЬЗОВАНИЯ УКАЗАННЫХ АНТИТЕЛ
|
|
PL1976877T5
(pl)
|
2005-11-30 |
2017-09-29 |
Abbvie Inc |
Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania
|
|
AU2007210862A1
(en)
|
2006-02-02 |
2007-08-09 |
Rinat Neuroscience Corp. |
Methods for treating unwanted weight loss or eating disorders by administering a trkB agonist
|
|
CA2685492C
(en)
|
2006-05-31 |
2018-01-16 |
The Brigham And Women's Hospital, Inc. |
Abcb5 positive mesenchymal stem cells as immunomodulators
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
US8648169B2
(en)
*
|
2006-12-05 |
2014-02-11 |
The Royal Institution For The Advancement Of Learning/Mcgill University |
Methods of use of Trk receptor modulators
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
US8895004B2
(en)
|
2007-02-27 |
2014-11-25 |
AbbVie Deutschland GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
PL2155248T3
(pl)
|
2007-04-12 |
2015-12-31 |
Brigham & Womens Hospital Inc |
Celowanie w ABCB5 w terapii nowotworowej
|
|
US8168757B2
(en)
*
|
2008-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
PD-1 binding proteins
|
|
JP5758289B2
(ja)
*
|
2008-05-21 |
2015-08-05 |
サントル、ナショナール、ド、ラ、ルシェルシュ、シアンティフィク、（セーエヌエルエス） |
ＮＴ−３：ＴｒｋＣ結合の阻害および神経芽腫などの癌の処置へのその適用
|
|
SI2350075T1
(sl)
|
2008-09-22 |
2014-06-30 |
Array Biopharma, Inc. |
Substituirane imidazo (1,2b)piridazinske spojine kot Trk kinazni inhibitorji
|
|
CN102264736B
(zh)
|
2008-10-22 |
2013-08-14 |
阵列生物制药公司 |
作为TRK激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物
|
|
US11542328B2
(en)
|
2008-11-14 |
2023-01-03 |
The Brigham And Women's Hospital, Inc. |
Therapeutic and diagnostic methods relating to cancer stem cells
|
|
ES2796111T3
(es)
|
2008-11-14 |
2020-11-25 |
Brigham & Womens Hospital Inc |
Métodos terapéuticos relacionados con células madre cancerosas
|
|
HRP20150831T1
(hr)
|
2008-12-19 |
2015-10-09 |
Biogen International Neuroscience Gmbh |
Humana anti-alfa- sinuklein auto-protutijela
|
|
US20100272640A1
(en)
|
2009-04-24 |
2010-10-28 |
Ozge Alper |
Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
IN2015DN02826A
(enExample)
*
|
2009-09-03 |
2015-09-11 |
Merck Sharp & Dohme |
|
|
WO2011130377A2
(en)
|
2010-04-15 |
2011-10-20 |
Abbott Laboratories |
Amyloid-beta binding proteins
|
|
BR122019024201B1
(pt)
|
2010-05-20 |
2021-08-03 |
Array Biopharma Inc |
Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica
|
|
KR20130048240A
(ko)
|
2010-07-14 |
2013-05-09 |
알퍼 바이오테크, 엘엘씨 |
Ｐｃｂｐ―１ 항원에 대한 모노클로날 항체, 및 그의 용도
|
|
US9062101B2
(en)
|
2010-08-14 |
2015-06-23 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
WO2012027821A1
(en)
*
|
2010-09-03 |
2012-03-08 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
A trkc receptor agonist antibody to treat neurodegenerative and motor neuron diseases
|
|
US9783601B2
(en)
|
2010-12-01 |
2017-10-10 |
Alderbio Holdings Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
|
US9078878B2
(en)
|
2010-12-01 |
2015-07-14 |
Alderbio Holdings Llc |
Anti-NGF antibodies that selectively inhibit the association of NGF with TrkA, without affecting the association of NGF with p75
|
|
US9539324B2
(en)
|
2010-12-01 |
2017-01-10 |
Alderbio Holdings, Llc |
Methods of preventing inflammation and treating pain using anti-NGF compositions
|
|
US11214610B2
(en)
|
2010-12-01 |
2022-01-04 |
H. Lundbeck A/S |
High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as Pichia pastoris
|
|
US9067988B2
(en)
|
2010-12-01 |
2015-06-30 |
Alderbio Holdings Llc |
Methods of preventing or treating pain using anti-NGF antibodies
|
|
US9884909B2
(en)
|
2010-12-01 |
2018-02-06 |
Alderbio Holdings Llc |
Anti-NGF compositions and use thereof
|
|
EP4086338A1
(en)
*
|
2011-03-17 |
2022-11-09 |
Minerva Biotechnologies Corporation |
Method for making pluripotent stem cells
|
|
PL2723379T3
(pl)
|
2011-06-23 |
2019-05-31 |
Biogen Int Neuroscience Gmbh |
Cząsteczki wiążące przeciwko alfa-synukleinie
|
|
JP6293659B2
(ja)
*
|
2011-07-01 |
2018-03-14 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
抗プロペルジン抗体およびその使用
|
|
WO2013168117A2
(en)
*
|
2012-05-09 |
2013-11-14 |
Koninklijke Philips N.V. |
Interventional information brokering medical tracking interface
|
|
US9926366B2
(en)
|
2012-10-04 |
2018-03-27 |
Novelmed Therapeutics, Inc. |
Methods of treating a hemolytic disorder comprising administering anti-properdin antibodies
|
|
TWI746426B
(zh)
|
2014-11-16 |
2021-11-21 |
美商亞雷生物製藥股份有限公司 |
(S)-N-(5-((R)-2-(2,5-二氟苯基)-吡咯啶-1-基)-吡唑并[1,5-a]嘧啶-3-基)-3-羥基吡咯啶-1-甲醯胺硫酸氫鹽結晶型
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
HK1253093A1
(zh)
|
2015-06-01 |
2019-06-06 |
Loxo Oncology Inc. |
诊断和治疗癌症的方法
|
|
SG11201707815RA
(en)
|
2015-06-05 |
2017-12-28 |
Novartis Ag |
Antibodies targeting bone morphogenetic protein 9 (bmp9) and methods therefor
|
|
CA2992586A1
(en)
|
2015-07-16 |
2017-01-19 |
Array Biopharma, Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
|
|
EP3328898B8
(en)
|
2015-07-28 |
2024-04-10 |
6452728 Canada Corp. |
Trkb or trkc agonist compositions and methods for the treatment of otic conditions
|
|
EP3368039A1
(en)
|
2015-10-26 |
2018-09-05 |
The Regents of The University of Colorado, A Body Corporate |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
PT3370768T
(pt)
*
|
2015-11-03 |
2022-04-21 |
Janssen Biotech Inc |
Anticorpos que se ligam especificamente ao pd-1 e seus usos
|
|
WO2017117384A1
(en)
|
2015-12-31 |
2017-07-06 |
Development Center For Biotechnology |
Anti-vegfr antibody and uses thereof
|
|
UA125025C2
(uk)
|
2016-04-04 |
2021-12-29 |
Локсо Онколоджі, Інк. |
Способи лікування дитячих ракових захворювань
|
|
UA125026C2
(uk)
|
2016-04-04 |
2021-12-29 |
Локсо Онколоджі, Інк. |
РІДКІ КОМПОЗИЦІЇ (S)-N-(5-((R)-2-(2,5-ДИФТОРФЕНІЛ)ПІРОЛІДИН-1-ІЛ)ПІРАЗОЛО[1,5-a]ПІРИМІДИН-3-ІЛ)-3-ГІДРОКСИПІРОЛІДИН-1-КАРБОКСАМІДУ
|
|
MX392604B
(es)
|
2016-05-18 |
2025-03-24 |
Array Biopharma Inc |
Procesos para la preparacion de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)-pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidin-1-carboxamida y sales del mismo.
|
|
EP3478269A4
(en)
|
2016-06-29 |
2020-04-08 |
Otonomy, Inc. |
OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
|
|
TWI752098B
(zh)
|
2016-10-10 |
2022-01-11 |
美商亞雷生物製藥股份有限公司 |
作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
|
TWI704148B
(zh)
|
2016-10-10 |
2020-09-11 |
美商亞雷生物製藥股份有限公司 |
作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
EP3559045A4
(en)
*
|
2016-12-23 |
2020-08-19 |
REMD Biotherapeutics, Inc. |
IMMUNOTHERAPY USING ANTIBODIES THAT BIND TO A TIMED DEATH LIGAND 1 (PD-L1)
|
|
WO2018136663A1
(en)
|
2017-01-18 |
2018-07-26 |
Array Biopharma, Inc. |
Ret inhibitors
|
|
JP6888101B2
(ja)
|
2017-01-18 |
2021-06-16 |
アレイ バイオファーマ インコーポレイテッド |
ＲＥＴキナーゼ阻害剤としての置換ピラゾロ［１，５−ａ］ピラジン化合物
|
|
CN114940713B
(zh)
*
|
2017-03-15 |
2024-04-30 |
清华大学 |
抗trkb抗体
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
EP3648757A4
(en)
*
|
2017-07-03 |
2020-11-25 |
Development Center for Biotechnology |
ANTI-VEGFR ANTIBODIES AND ITS USES
|
|
MD3672631T3
(ro)
|
2017-08-22 |
2023-09-30 |
Biogen Ma Inc |
Compoziții farmaceutice conținând anticorpi anti-beta amiloidici
|
|
US11786551B2
(en)
|
2017-09-26 |
2023-10-17 |
The Trustees Of The University Of Pennsylvania |
Methods for treating heart disease via redirected T cell immunotherapies
|
|
TWI876442B
(zh)
|
2017-10-10 |
2025-03-11 |
美商絡速藥業公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
|
|
TWI791053B
(zh)
|
2017-10-10 |
2023-02-01 |
美商亞雷生物製藥股份有限公司 |
6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
|
|
WO2019075433A1
(en)
*
|
2017-10-13 |
2019-04-18 |
Adimab, Llc |
ANTIBODIES AGAINST SYNCYTIAL RESPIRATORY VIRUS AND METHODS FOR THEIR GENERATION AND USE
|
|
CA3080157A1
(en)
|
2017-10-26 |
2019-05-02 |
Array Biopharma Inc. |
Formulations of a macrocyclic trk kinase inhibitor
|
|
EP3740491A1
(en)
|
2018-01-18 |
2020-11-25 |
Array Biopharma, Inc. |
Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors
|
|
EP3740486A1
(en)
|
2018-01-18 |
2020-11-25 |
Array Biopharma, Inc. |
Substituted pyrazolyl[4,3-c]pyridinecompounds as ret kinase inhibitors
|
|
CN111630054B
(zh)
|
2018-01-18 |
2023-05-09 |
奥瑞生物药品公司 |
作为RET激酶抑制剂的取代的吡唑并[3,4-d]嘧啶化合物
|
|
US12398209B2
(en)
|
2018-01-22 |
2025-08-26 |
Janssen Biotech, Inc. |
Methods of treating cancers with antagonistic anti-PD-1 antibodies
|
|
EP3773725A1
(en)
|
2018-03-29 |
2021-02-17 |
Loxo Oncology Inc. |
Treatment of trk-associated cancers
|
|
CA3108065C
(en)
|
2018-07-31 |
2025-10-07 |
Loxo Oncology, Inc. |
SPRAY-DRIED DISPERSIONS, FORMULATIONS AND POLYMORPHIES OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE
|
|
ES2922314T3
(es)
|
2018-09-10 |
2022-09-13 |
Array Biopharma Inc |
Compuestos heterocíclicos condensados como inhibidores de cinasa RET
|
|
US12351571B2
(en)
|
2018-12-19 |
2025-07-08 |
Array Biopharma Inc. |
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases
|
|
WO2020131627A1
(en)
|
2018-12-19 |
2020-06-25 |
Array Biopharma Inc. |
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases
|
|
BR112022005423A2
(pt)
|
2019-09-23 |
2022-06-21 |
Univ Pennsylvania |
Interrupção de tecidos tumorais por alvejamento de proteína de ativação de fibroblasto (fap)
|
|
CN114761036B
(zh)
|
2019-09-23 |
2025-09-30 |
宾夕法尼亚大学董事会 |
与小鼠和人成纤维细胞激活蛋白(fap)交叉反应的抗犬成纤维细胞激活蛋白单克隆抗体
|
|
CN117447602B
(zh)
*
|
2023-12-22 |
2024-03-19 |
北京索莱宝科技有限公司 |
猪IgM的抗体及其应用
|
